CLSA on Cadila Health
Buy, TP Rs 285
Attractive val of 15x FY21CL earnings
Believe expectations on earnings & monetization of innovation portfolio are quite modest, & even a small positive surprise can drive a PE re-rating
Feedback
ZYDUSLIFE 
Reputation: 13,324 • Sep 5, 2019 1:19 PM
Vote
Comment
Share